Dedicated oncologist Natasha Tiffany, MD, practices at Oregon Oncology Specialists as a physician partner. In this capacity, she sees patients at both Salem Hospital and at the clinic. In addition, Natasha Tiffany, MD, is an attending physician and affiliate assistant professor at Oregon Health Sciences University, and is committed to improving cancer care in the area.
Compared to the rest of the country, Oregon has one of the lowest new cancer rates, yet the death rate in the state rests around the middle. The American Cancer Society estimates that about only 23,300 new cancer cases will be diagnosed in Oregon in 2019, but roughly 8,270 residents in the state will die because of cancer in that same year. The majority of these deaths will result from lung and bronchus cancers. These types of cancers are believed to be the second most common type of cancer in 2019, following female breast cancer. Breast cancer is the most common type of cancer seen in Oregon, particularly in Lake, Clackamas, Josephine, and Yamhill Counties. Although the American Cancer Society estimates state that lung and bronchus cancer will be the second most common type of cancer in the state in 2019, prostate has historically come in second, and lung cancers in third. These cancers affect roughly 2,358 and 2,682 Oregonians per year, respectively.
0 Comments
Leave a Reply. |
AuthorNatasha Tiffany, MD, is a physician, educator, and research scientist currently working in Oregon. A Partner and Physician in a private practice located in the state’s capital city of Salem, Dr. Tiffany teaches at her alma mater, Oregon Health & Science University, where she is an Affiliate Assistant Professor in the Hematology and Medical Oncology Division. Archives
October 2019
Categories
All
|